Introduction: Although pleural effusion is a common clinical manifestation, the differential diagnosis of the cause of the pleural effusion is often challenging, especially in the early differentiation of tuberculous pleurisy (TP) from other pleural effusion.
INTRODUCTION
Tuberculosis accounts for millions of active disease cases and deaths in both developed and developing countries (1) . The proportion of patients with tubercu-losis who have pleural effusions has varied markedly from population to population (1, 2) . Tuberculous pleural effusion occurs in approximately 5% of patients with Mycobacterium tuberculosis (TB) infection and accounts for 4% of all TB cases in the United States (2). Diagnosis is challenging, with 48-96% of tuberculous pleural effusions negative by sputum acid-fast bacilli (AFB) stain and culture (3, 4) . Thoracentesis is frequently performed and shows an exudative, lymphocytic pleural effusion in more than 90% of cases but direct examination reveals acid-fast bacilli (AFB) in less than 10% of cases (5, 6) . As AFB stain and cultures are often negative and biomarkers cannot guide therapy, more invasive diagnostic measures are usually required. The following case illustrates the clinical presentation and diagnostic approach in anatypical caseof suspected tuberculous pleural effusion, which presented typically eventuallyin a previouslyhealthy man, as well as review of literature.
CASE REPORT
A male temporary resident of Russian descent, 51 years of age, was referred by a general practitioner (GP) to our hospital because of routinely annually done chest x ray which showed left sided pleural effusion for further diagnostic. The patient reported that he is mechanical engineer who work in Serbia for 5 years in comfort surroundings. He had not traveled in the past few years.He observed that he had weight lossof 7 kilograms in last 6 months, apart from good appetite,but no shortness of breath at rest, chest pain, fevers, or sick contacts. He had never smoked. He had no infectious contacts or a history of tuberculosis (TB) or immuno-suppression. One week prior to presentation, he was empirically treated for pneumonia with levofloxacin without improvement.
On admission the patient was afebrile, with normal blood pressure, 120/80mmHg, a heart rate of 110 beats/min, and S pO2 of 96% while breathing room air. Cardiac sounds were clear. Physical examination revealed dullness to percussion and decreased breath sounds throughout his lefthemithorax, with normal lung sounds on the right. She had no abdominal hepatosplenomegaly or edema of either lower limb. His white blood cell count was 12 x 10 9 /Lwith 73% neutrophils and 14% lymphocytes, and platelets 460 x 10 3 cells/ml.
Basic chemistry was normal, exceptC-reactive protein of 49 mg/L. A repeated chest radiograph ( Figure 1A ) revealed a large left pleural effusion ant it regression after thoracentesis (Figure 1 B, C). Chest computed tomographyshowed large pleural effusion on the left side with inflammatory changes in left lower lobe (Figure 1 D). Human immunodeficiency virus (HIV) test was negative. Expectorated sputum revealed 3 negative stains and cultures for acid-fast -bacillus (AFB). The Quanti-FERON-TB Gold (QFT)test was indeterminate. We have done three thoracentesis. Pleural fluid was an exudate with lymphocytic predominance in 90% of cases.A percutaneous, closed pleural biopsy was performed, using an Abrams needle, yielding 6 pieces of pleural tissue that revealed granulomatous pleuritis with focal necrosis, positive by AFB stain. The patient was started on an anti-tuberculosis regimen (isoniazid (INH) 300 mg, ethambutol (EMB) 800 mg, rifampin (RIF) 450 mg and pyrazinamide (PZA) 1000 mg) for two months and tolerate well on first control examination. The next phase of the treatment should be INH and rifampin for 4 months. Directly observed therapy (DOT) is recommended. It is also possible to use 9-month therapy of INH and rifampin if the organisms are fully susceptible to the drug (7) .
DISCUSSION
Tuberculous pleuritis usually presents as an acute or subacute illness. Symptoms are present for less than 1 week in 35% of patients and present for less than 1 month in 71% (7) . The most frequent symptoms are cough (¬70%), which is usually non-productive, and chest pain (¬70%), which is usually pleuritic (8) . Most patients are febrile, but approximately 15% will be afebrile (7, 8) . They may also be dyspneic if the effusion is large. If the presentation is less acute, mild chest pain may occur with at most a low-grade fever, non-productive cough, weight loss, and malaise (9) . Our patient had none of symptoms mentioned above, except weight loss, to whom he did not attribute significance due to irregular meals. He had no contagious contact.
Tuberculous pleural effusion (TPE) results from Mycobacterium tuberculosis infection of the pleura and is characterized by an intense chronic accumulation of fluid and inflammatory cells in pleural space (10) . TPE is the second most common form of extrapulmonary tuberculosis and a common cause of pleural effusions in endemic tuberculosis areas. TPE is usually unilateral and can be of any size. In the studies of large number population, pleural fluid occurred only on the left side in 127 (38.1%), only on the right in 161 (48.4%), and both sides were affected in 45 (13.5%). In either unilateral or bilateral effusion, the percentages of small, moderate, and large size of pleural effusions were 20.4%, 19.2%, and 60.4%, respectively (2, 8). Approximately 20% of patients with TPE have coexisting parenchymal disease on chest radiograph. However, computed tomography scanning offers a more sensitive method and can demonstrate parenchymal disease in 40-85% of cases (11) .
TPE predominates in men, with an overall male-to-female ratio of 2 : 1 (4, 12) . In an epidemiological analysis from the United States, TPE occurs significantly more often than pulmonary tuberculosis among persons > 65 years old, and the mean age of patients with TPE is 49 years: about 50% were younger than 45 years and 30% were over 65 years of age. In contrast, TPE affects mainly younger individuals (mean age = 34 years) in higher tuberculosis burden areas, where primary infection accounts for a large percentage of patients with TPE (2, 13). Immunocompromised pati- ents are more likely to develop TB than non-immunocompromised patients. Because TB pleuritis is thought to be due to delayed hypersensitivity, one might hypothesize that the percentage of immunocompromised hosts with TB with pleural effusions would be lower than in immunocompetent hosts, which is not always a case (14, 15) . The incidence of tuberculosis in Serbia shows a trend of swelling and it is estimated that premature data from the Institute of Public Health from 2018 is 10, 52% of which 89% are pulmonary forms of tuberculosis (16). The best diagnostic approach to suspected tuberculous pleuritis is debated. The yield of pleural fluid smears is 10% and of pleural fluid cultures is 25-85% (4, 17) . Pleural biopsy histopathology of granulomas or (+) culture has diagnostic yields ranging from 55 to 93%. Evaluation for TB with thoracentesis plus closed pleural biopsy has a 95% sensitivity, which is roughly on par with thoracoscopy. Diagnostic modalities with highest yield are slow to show results making acute workup difficult (4, 17) .
The American Thoracic Society recommends a 6-month regimen for treatment of pleural TB consisting of a 2-month period of Isoniazid (INH), Rifampin (RIF), Ethambutol (EMB) and Pyrazinamide (PZA) and followed by INH and RIF daily for 4 months (17). Corticosteroids have not reduced residual pleural thickening and are not recommended (17, 18, 19) . Therapeutic thoracentesis is not discussed in the guidelines and is controversial, however it is usually performed if a patient is more than mildly symptomatic (17) . Significantly less residual pleural thickening and accelerated recovery of pulmonary function has been seen in patients who received therapeutic thoracentesis for TB associated effusions (19, 20) . However, other studies have concluded that residual pleural thickening is not influenced by this intervention (18, 19, 20) . Other drawbacks to thoracentesis include risk of transmission to health providers, bleeding, and pulmonary injury. Anyway, it's still a subject of study and further analysis perhaps would show the real path.
CONCLUSION
The diagnosis of TB pleuritis should be considered when a patient presents with new pleural effusion. The gold standard for the diagnosis of tuberculous pleural effusion remains the detection of Mycobacterium tuberculosis in pleural fluid, or pleural biopsy specimens, either by microscopy and/or culture, or the histological demonstration of caseating granulomas in the pleura along with acid fast bacilli. If the diagnosis is not made, the patient is at risk for developing pulmonary or extrapulmonary tuberculosis.The recommended treatment for TB effusion is a regimen with Isoniazid, Rifampin, Ethambutol and Pyrazinamide for two months followed by four months of two drugs, isoniazid and rifampin.
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